MARYANNA SAENKO

Profile

First Name

: MARYANNA

Middle Name

:

Last Name

: SAENKO

Related Companies
Titles
Company Name
Related People
DIRECTOR
FUTURE VENTURES, L.P.
N/A FUTURE VENTURES GP LLC, STEVE JURVETSON
DIRECTOR
FUTURE VENTURES SIDE FUND, L.P.
N/A FUTURE VENTURES GP LLC, STEVE JURVETSON
DIRECTOR
OCKAM INC.
MATTHEW GREGORY, LOGAN JAGER, PATRICIA MUOIO
DIRECTOR
FUTURE VENTURES FINAL FRONTIER FUND, LLC
N/A FUTURE VENTURES GP LLC, STEVE JURVETSON
DIRECTOR
FUTURE VENTURES II, L.P.
N/A FUTURE VENTURES GP II, LLC, STEVE JURVETSON
DIRECTOR
FUTURE VENTURES SIDE FUND II, L.P.
N/A FUTURE VENTURES GP II, LLC, STEVE JURVETSON
DIRECTOR
FUTURE VENTURES FINAL FRONTIER FUND II, LLC
N/A FUTURE VENTURES GP II, LLC, STEVE JURVETSON
DIRECTOR
CAMBRIAN BIOPHARMA INC
CHRISTIAN ANGERMAYER, CHRISTIAN ANGERMEYER, PAUL FARR, JAMES G. PEYER, BRENTON SAUNDERS
DIRECTOR
FUTURE VENTURES COMMONWEALTH FUSION FUND, LLC
N/A FUTURE VENTURES GP, LLC, STEVE JURVETSON
DIRECTOR
GAMETO, INC.
JONATHAN HOSTENS, DYLAN MORRIS, DUSAN PEROVIC, DINA RADENKOVIC, KRISTINA SIMMONS, MARTIN VARSAVSKY
DIRECTOR
FUTURE VENTURES FINAL FRONTIER FUND III, LLC
N/A FUTURE VENTURES GP II, LLC, STEVE JURVETSON
DIRECTOR
EARTHSHOT LABS PBC
TROY CARTER, DEREK CHAU, TREVOR KEENAN, PATRICK LEUNG, ROSS LUKATSEVTICH
DIRECTOR
FUTURE VENTURES AI, LLC
N/A FUTURE VENTURES GP III, LLC, STEVE JURVETSON
DIRECTOR
FUTURE VENTURES IV, L.P.
N/A FUTURE VENTURES GP IV, LLC, STEVE JURVETSON
DIRECTOR
FUTURE VENTURES SIDE FUND IV, L.P.
N/A FUTURE VENTURES GP IV, LLC, STEVE JURVETSON
DIRECTOR
REALTA FUSION INC.
ALICE BROOKS, CARY FOREST, KIERAN FURLONG
DIRECTOR
FUTURE VENTURES COMMONWEALTH FUSION FUND II, LLC
N/A FUTURE VENTURES GP III, LLC, STEVE JURVETSON
DIRECTOR
FUTURE VENTURES COMMONWEALTH FUSION FUND II (BLOCKER), LLC
N/A FUTURE VENTURES GP III, LLC, STEVE JURVETSON
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-08-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-07-21 
2025-08-12
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2025-07-01 
2025-08-12
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2025-07-01 
2025-05-13
D
Link
OTHER ENERGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-05-01 
2025-05-06
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2025-05-02 
2025-05-06
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2025-05-02 
2025-01-13
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2023-06-02 
2024-05-30
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2024-05-09 
2024-05-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-05-20 
2024-05-13
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2024-04-29 
2024-05-13
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2023-04-13 
2023-12-22
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2023-06-02 
2022-09-27
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-18 
2022-09-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-06-10 
2022-09-07
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-10 
2022-06-03
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2022-05-27 
2022-03-30
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2021-11-19 
2022-01-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-10 
2021-12-17
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-03 
2021-12-02
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-13 
2021-05-06
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2020-10-20 
2021-03-05
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2021-02-16 
2021-01-20
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2021-01-19 
2021-01-12
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2021-01-12 
2020-08-06
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2020-07-31 
2019-11-07
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2019-05-06 
2019-11-07
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2019-10-10 
2019-02-15
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2019-02-14 
2019-02-15
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2019-01-31